These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 22207004)
1. Altered CSF orexin and α-synuclein levels in dementia patients. Wennström M; Londos E; Minthon L; Nielsen HM J Alzheimers Dis; 2012; 29(1):125-32. PubMed ID: 22207004 [TBL] [Abstract][Full Text] [Related]
2. CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease. Reesink FE; Lemstra AW; van Dijk KD; Berendse HW; van de Berg WD; Klein M; Blankenstein MA; Scheltens P; Verbeek MM; van der Flier WM J Alzheimers Dis; 2010; 22(1):87-95. PubMed ID: 20847452 [TBL] [Abstract][Full Text] [Related]
3. CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies. Luo X; Hou L; Shi H; Zhong X; Zhang Y; Zheng D; Tan Y; Hu G; Mu N; Chan J; Chen X; Fang Y; Wu F; He H; Ning Y J Neurochem; 2013 Dec; 127(5):681-90. PubMed ID: 23800322 [TBL] [Abstract][Full Text] [Related]
4. CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease. Noguchi-Shinohara M; Tokuda T; Yoshita M; Kasai T; Ono K; Nakagawa M; El-Agnaf OM; Yamada M Brain Res; 2009 Jan; 1251():1-6. PubMed ID: 19071095 [TBL] [Abstract][Full Text] [Related]
5. Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias. Bibl M; Mollenhauer B; Lewczuk P; Esselmann H; Wolf S; Trenkwalder C; Otto M; Stiens G; Rüther E; Kornhuber J; Wiltfang J Mol Psychiatry; 2007 Jul; 12(7):671-80. PubMed ID: 17339876 [TBL] [Abstract][Full Text] [Related]
6. CSF amyloid-β peptides in neuropathologically diagnosed dementia with Lewy bodies and Alzheimer's disease. Mollenhauer B; Esselmann H; Trenkwalder C; Schulz-Schaeffer W; Kretzschmar H; Otto M; Wiltfang J; Bibl M J Alzheimers Dis; 2011; 24(2):383-91. PubMed ID: 21297274 [TBL] [Abstract][Full Text] [Related]
7. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration. Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202 [TBL] [Abstract][Full Text] [Related]